July 14, 2025 a 12:38 pm
CAH: Analysts Ratings - Cardinal Health, Inc.
Cardinal Health, Inc. has experienced fluctuating analyst ratings over recent months, showing a gradual shift in sentiment. Investor confidence seems moderate, with a cautious approach observed in the marketplace. The company's diverse operations across healthcare sectors present both opportunities and challenges, reflected in the mixed analyst expectations.
Historical Stock Grades
| Recommendation | Count | Score Bar |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 10 | |
| Hold | 4 | |
| Sell | 0 | |
| Strong Sell | 1 |
Sentiment Development
The trend for Cardinal Health reveals a gradual shift towards more moderate positions, with a slight increase in Buy ratings and a decline in Hold positions over the past few months. Historically strong buy recommendations have remained stable, hinting at a possible consolidation in investor sentiment.
- Notable increase in Buy recommendations from February to July 2025.
- A reduction in Hold ratings suggests increased investor confidence.
- Strong Buy recommendations show consistency, indicating ongoing optimism.
Percentage Trends
Analyzing percentage trends, a significant shift is apparent with Buy recommendations surging since the beginning of 2025. This is indicative of growing confidence in the company’s strategic initiatives. Meanwhile, Hold ratings have witnessed a minor yet noticeable dip.
- From June to July 2025, Buy recommendations account for 50% of the total interest.
- Strong Buy stands consistently at 10%, showcasing stable investor outlook.
- Hold ratings have decreased, ultimately capturing only 20% in July 2025.
- Strong Sell remains low, representing 5% of the sentiment, hinting at limited bearish perspectives.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-13 | Overweight | Overweight | Morgan Stanley |
| 2025-06-13 | Neutral | Neutral | Citigroup |
| 2025-06-12 | Outperform | Outperform | Evercore ISI Group |
| 2025-06-10 | Buy | Buy | B of A Securities |
| 2025-06-03 | Overweight | Equal Weight | Wells Fargo |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-03 | Overweight | Equal Weight | Wells Fargo |
| 2025-02-05 | Buy | Hold | Jefferies |
| 2025-01-08 | Buy | Hold | TD Cowen |
| 2025-01-07 | Outperform | In Line | Evercore ISI Group |
| 2025-01-06 | Buy | Neutral | B of A Securities |
Interpretation
Given the diverse nature of the recommendations, it's clear that while some confidence persists, there is also reticence among analysts reflecting a cautious stance. The stability in strong buy recommendations indicates a positive current underlying corporate strategy, but the mixed signals in the broader recommendations could point to uncertainty associated with external economic conditions or sector-specific challenges. The subtle improvements in sentiment could hint at growing trust, but further consistency in upgrades is needed for a more definitive bullish perspective.
Conclusion
The analysis of Cardinal Health, Inc. reveals a complex sentiment landscape where cautious optimism prevails amid an evolving market. The modest increase in buy recommendations speaks to potential growth opportunities for the company, while the consistent hold and sell ratings remind investors of underlying risks. While recent upgrades in recommendations provide a positive signal, the enduring presence of a significant number of holds suggests a need for strategic enhancements to sway sentiment more decisively. Investors may consider these mixed signals and stay attuned to external economic factors influencing the healthcare market.